ANNA MAIZLIN: Open Payments
NPI 1639594864 · LEES SUMMIT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,411 in 41 payments from 16 companies in 2025. Trend: 2023 $698 · 2024 $1,550 · 2025 $2,411
Travel & lodging: $1,212Food & beverage: $1,198
| Company | Payments | Amount |
|---|---|---|
| Saluda Medical Americas, Inc. | 9 | $1,755 |
| Collegium Pharmaceutical, Inc. | 9 | $150 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $69 |
| PROTEGA PHARMACEUTIALS INC | 4 | $68 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $63 |
| Medtronic, Inc. | 1 | $60 |
| Forte Bio-Pharma LLC | 2 | $45 |
| ABBVIE INC. | 2 | $34 |
| Nalu Medical, Inc. | 1 | $27 |
| Fidia Pharma USA Inc. | 1 | $27 |
Products named: Evoke, Belbuca, ROXYBOND, RELISTOR, INCEPTIV, XTAMPZA, PROLATE, Nalu Neurostimulation System.
Industry payments across MO — which companies pay providers there.
